JF
Jonathan Friedlander
Senior Director Corporate Development at Agenus
Greater Boston
Overview
Jonathan Friedlander is a highly accomplished biotechnology professional currently serving as the Senior Director of Corporate Development at Agenus. With a background in molecular biology and genetics, he has held key roles such as Chief Operating Officer at Alcea Therapeutics and Principal at Digitalis Ventures, showcasing his expertise in bioinformatics, cancer research, and genetic engineering.
Friedlander's career highlights include his experience at Flagship Pioneering as an Associate and his educational background with a Ph.D. from the University of Cambridge, demonstrating a strong foundation in life sciences and business strategy.
Work Experience
Senior Director Corporate Development
2024 - Current
Chief Operating Officer
2021
Principal
2018 - 2024
Digitalis is a venture capital firm that that invests in solutions to complex problems in human and animal health.
Associate
2017 - 2018
Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.
Summer Fellow
2016 - 2016
Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.
Research scientist
2012 - 2015
Graduate Student Researcher
2007 - 2012
Research Assistant
2006 - 2006
Renal Division, Al-Awqati Lab. Localisation and description of renal stem cells
Intern
2005 - 2005
Agricultural development